Head Biomarkers And Biopharmaceuticals
CurrentEdwin Janssen is trained as a molecular (cell) biologist and has been the Head of the Biomarker and Biopharmaceutical Department of Eurofins since 2009. Before joining Eurofins, he gained several years of postdoctoral experience in cell (tumour) metabolism after joining Schering-Plough (former Organon) in 2005. At Schering-Plough, he participated in lead finding and lead optimization teams on contraception, inflammatory diseases and oncology with a focus on the discovery, development and implementation of biomarkers in lead optimization programs and proof of concept studies. Currently, he is heading the Biomarkers and Biopharmaceutical department at Eurofins, Breda. In this role, he develops and supports projects for the pharma and biotech industry related to PK/Immunogenicity of Biopharmaceuticals and Biomarker applications in (pre)clinical trials.